We would like to inform that the, there is typographical error in Limited Review Report for Standalone Financail Results for the Quarter Ended 31st December 2025 now corrected (wrong period ....
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Triochem Products has re-submitted its unaudited standalone financial results for Q3FY26 (quarter and nine months ended 31 December 2025) after fixing a typographical error in the Limited Review Report, which had incorrectly mentioned the period as 31 December 2024 instead of 31 December 2025. The actual financial numbers remain unchanged. Revenue from operations fell sharply to Rs 22.06 lakhs in Q3FY26 from Rs 45.85 lakhs in Q3FY25, a drop of about 52%. The company posted a net loss of Rs 13.18 lakhs in Q3FY26 and Rs 35.50 lakhs for the nine months, compared to a small profit of Rs 5.17 lakhs in the same nine-month period last year. Statutory auditor Kanu Doshi Associates LLP issued an unqualified review conclusion. Note 4 discloses a proposed sale of immovable properties, plant & machinery, and investment property in Maharashtra, classified as a Material Related Party Transaction, with shareholder approval received via postal ballot on 13 December 2025 and expected completion by 31 March 2026.
The re-submission is procedural and does not change the underlying results; shareholders should note the steep revenue decline and continued losses, but the planned monetisation of non-core assets (fair market value around Rs 1,181 lakhs vs written down value of Rs 56.92 lakhs) could be a significant positive catalyst if completed by March 2026.